ikarishingi的个人主页 - 老虎社区

ikarishingi

ikarishingi

暂无个人介绍

IP属地：未知

5关注

0粉丝

0主题

0勋章

2021-10-23

Tesla to the moon

Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote>

2021-10-22

What a drastic droo

抱歉，原内容已删除

2021-03-19

Tesla to the moon

Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3576884931619523","uuid":"3576884931619523","gmtCreate":1613790907707,"gmtModify":1616164535732,"name":"ikarishingi","pinyin":"ikarishingi","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.10","exceedPercentage":"80.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":858088875,"gmtCreate":1634953290793,"gmtModify":1634954241447,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858088875","repostId":"1166213725","repostType":4,"repost":{"id":"1166213725","kind":"news","pubTimestamp":1634948473,"share":"https://www.laohu8.com/m/news/1166213725?lang=zh_CN&edition=full","pubTime":"2021-10-23 08:21","market":"us","language":"en","title":"Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166213725","media":"Barrons","summary":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?Tesla  stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.Tesla stoc","content":"<p>Tesla&nbsp;stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高，收盘价创历史新高。该股最近的走势令人难以置信。能涨到多高？</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The&nbsp;S&amp;P 500&nbsp;dropped about 0.1%, while the&nbsp;Dow Jones Industrial Average&nbsp;added about 0.2%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收于909.68美元，上涨约1.8%。标准普尔500指数下跌约0.1%，道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&amp;P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五，标准普尔的信用升级也提振了股价。特斯拉债务目前评级为BB+，比投资级低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股价创52周盘中新高910美元。根据道琼斯市场数据，900.40美元的旧高水位是在1月25日创下的。周四，特斯拉自1月26日以来首次收于创纪录水平。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月，股价上涨了约40%，市值达到约9100亿美元。（特斯拉拥有约10亿股已发行股票，这使得计算变得很容易。）</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到未来会有更多收益。Wedbush分析师Dan Ives将牛市特斯拉股价目标从1300美元上调至1500美元，此前该公司周三公布了好于预期的财报。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“特斯拉正在上涨，因为盈利修正正在飙升，”未来基金主动交易所交易基金管理合伙人Gary Black指出。过去几周，分析师对特斯拉2022年每股收益的预期已从每股6美元升至约8美元。“不断上涨的估值推动特斯拉在2020年登上了月球。它们将推动特斯拉在2022年达到1,000美元以上，”Black说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>Ives将特斯拉股票评级为买入，特斯拉是Black基金的最大持仓。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的，仍然有看空特斯拉的人认为该股被高估了。分析师目标价的底部三分之一平均约为425美元，不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票通常不会因为投资者集体某天早上醒来对估值有不同的感觉而下跌。总得有事发生。整体市场可能会暴跌，或者企业可能会陷入困境。分析师预计，特斯拉的交付量将从2021年的约89万辆增长到2022年的130万辆。增长的任何问题都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌，谁也说不准。不过，就目前而言，势头属于特斯拉多头。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-23 08:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla&nbsp;stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高，收盘价创历史新高。该股最近的走势令人难以置信。能涨到多高？</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The&nbsp;S&amp;P 500&nbsp;dropped about 0.1%, while the&nbsp;Dow Jones Industrial Average&nbsp;added about 0.2%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收于909.68美元，上涨约1.8%。标准普尔500指数下跌约0.1%，道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&amp;P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五，标准普尔的信用升级也提振了股价。特斯拉债务目前评级为BB+，比投资级低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股价创52周盘中新高910美元。根据道琼斯市场数据，900.40美元的旧高水位是在1月25日创下的。周四，特斯拉自1月26日以来首次收于创纪录水平。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月，股价上涨了约40%，市值达到约9100亿美元。（特斯拉拥有约10亿股已发行股票，这使得计算变得很容易。）</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到未来会有更多收益。Wedbush分析师Dan Ives将牛市特斯拉股价目标从1300美元上调至1500美元，此前该公司周三公布了好于预期的财报。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“特斯拉正在上涨，因为盈利修正正在飙升，”未来基金主动交易所交易基金管理合伙人Gary Black指出。过去几周，分析师对特斯拉2022年每股收益的预期已从每股6美元升至约8美元。“不断上涨的估值推动特斯拉在2020年登上了月球。它们将推动特斯拉在2022年达到1,000美元以上，”Black说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>Ives将特斯拉股票评级为买入，特斯拉是Black基金的最大持仓。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的，仍然有看空特斯拉的人认为该股被高估了。分析师目标价的底部三分之一平均约为425美元，不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票通常不会因为投资者集体某天早上醒来对估值有不同的感觉而下跌。总得有事发生。整体市场可能会暴跌，或者企业可能会陷入困境。分析师预计，特斯拉的交付量将从2021年的约89万辆增长到2022年的130万辆。增长的任何问题都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌，谁也说不准。不过，就目前而言，势头属于特斯拉多头。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166213725","content_text":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?\nTesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.\nShares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.\nTesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.\nShares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)\nBulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.\n“Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.\nIves rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.\nYes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.\nBears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.\nWhether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851090164,"gmtCreate":1634857328674,"gmtModify":1634857328782,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"What a drastic droo","listText":"What a drastic droo","text":"What a drastic droo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851090164","repostId":"2177640184","repostType":4,"isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":350945833,"gmtCreate":1616155073822,"gmtModify":1634526972633,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/350945833","repostId":"1197074607","repostType":4,"repost":{"id":"1197074607","kind":"news","pubTimestamp":1616152229,"share":"https://www.laohu8.com/m/news/1197074607?lang=zh_CN&edition=full","pubTime":"2021-03-19 19:10","market":"us","language":"en","title":"Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197074607","media":"Motley Fool","summary":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesT","content":"<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上升潜力。几乎每个人都知道凯西·伍德真的很喜欢<b>特斯拉</b>（纳斯达克：TSLA）。方舟投资管理公司创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时，伍德通常会为她雄心勃勃的交易所交易基金购买更多股票。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的ETF中的许多其他持股并没有受到那么多关注。然而，她本月早些时候在接受CNBC采访时指出了其中一只股票，称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它是否比特斯拉更值得买入？</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德特别提到了医学遗传学领导者<b>邀请</b>（纽约证券交易所股票代码：NVTA）是一只特别被低估的股票。该公司表示，其使命“是将全面的遗传信息带入主流医学，以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此，她管理的两只ETF持有Invitae的头寸也就不足为奇了。该股是该公司第11大持股<b>方舟创新ETF</b>和第17大持股<b>方舟基因组革命ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病遗传给孩子的风险，以及最合适的胚胎，以帮助确保在体外受精过程中确定健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中，Invitae过去12个月的收入猛增了2,400%以上。这一业绩超过了特斯拉同期约640%的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而，与特斯拉不同的是，Invitae尚未盈利。但这家基因检测公司在未来几年内有一条盈利之路，特别是随着最近收购ArcherDX和One Codex扩大Invitae的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去，基因检测的高成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本，打开了巨大潜在市场的大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae首席执行官肖恩·乔治(Sean George)上周告诉CNBC，基因检测的情况与大约四十年前计算和网络行业发生的情况类似。当时较低的半导体成本为市场爆炸奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大？Invitae认为其潜在市场总额每年超过1500亿美元。它预计，仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计，41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为，它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单，预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好？</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是，到目前为止，Invitae还没有像特斯拉那样成为大赢家。在过去五年中，医疗保健股的价值增长了五倍。然而，在同一时期，特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看，Invitae会比特斯拉更好吗？当在去年12月接受彭博社采访时被问及哪只股票可能在未来五年内推动ARK ETF的最大涨幅时，伍德承认特斯拉是其中之一。然而，她也表示，“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着Invitae一定是将成为未来主要意外赢家的基因组学股票。不过，也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司的市值目前仅为85亿美元左右。如果Invitae在其目标市场中占据两位数的份额，它可能会成为10家企业。尽管特斯拉取得了巨大的成功，但想象该股再次成为10袋股还有些牵强。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>现在Invitae可能比特斯拉更划算。不过，即使事实并非如此，该股也很有可能不会在太长时间内保持低估状态。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-19 19:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上升潜力。几乎每个人都知道凯西·伍德真的很喜欢<b>特斯拉</b>（纳斯达克：TSLA）。方舟投资管理公司创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时，伍德通常会为她雄心勃勃的交易所交易基金购买更多股票。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的ETF中的许多其他持股并没有受到那么多关注。然而，她本月早些时候在接受CNBC采访时指出了其中一只股票，称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它是否比特斯拉更值得买入？</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德特别提到了医学遗传学领导者<b>邀请</b>（纽约证券交易所股票代码：NVTA）是一只特别被低估的股票。该公司表示，其使命“是将全面的遗传信息带入主流医学，以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此，她管理的两只ETF持有Invitae的头寸也就不足为奇了。该股是该公司第11大持股<b>方舟创新ETF</b>和第17大持股<b>方舟基因组革命ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病遗传给孩子的风险，以及最合适的胚胎，以帮助确保在体外受精过程中确定健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中，Invitae过去12个月的收入猛增了2,400%以上。这一业绩超过了特斯拉同期约640%的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而，与特斯拉不同的是，Invitae尚未盈利。但这家基因检测公司在未来几年内有一条盈利之路，特别是随着最近收购ArcherDX和One Codex扩大Invitae的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去，基因检测的高成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本，打开了巨大潜在市场的大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae首席执行官肖恩·乔治(Sean George)上周告诉CNBC，基因检测的情况与大约四十年前计算和网络行业发生的情况类似。当时较低的半导体成本为市场爆炸奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大？Invitae认为其潜在市场总额每年超过1500亿美元。它预计，仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计，41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为，它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单，预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好？</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是，到目前为止，Invitae还没有像特斯拉那样成为大赢家。在过去五年中，医疗保健股的价值增长了五倍。然而，在同一时期，特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看，Invitae会比特斯拉更好吗？当在去年12月接受彭博社采访时被问及哪只股票可能在未来五年内推动ARK ETF的最大涨幅时，伍德承认特斯拉是其中之一。然而，她也表示，“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着Invitae一定是将成为未来主要意外赢家的基因组学股票。不过，也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司的市值目前仅为85亿美元左右。如果Invitae在其目标市场中占据两位数的份额，它可能会成为10家企业。尽管特斯拉取得了巨大的成功，但想象该股再次成为10袋股还有些牵强。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>现在Invitae可能比特斯拉更划算。不过，即使事实并非如此，该股也很有可能不会在太长时间内保持低估状态。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197074607","content_text":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesTesla(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.What is this underappreciated stock -- and could it be an even better buy than Tesla?It's in the genesWood singled out medical genetics leaderInvitae(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in theARK Innovation ETFand the 17th-largest holding in theARK Genomic Revolution ETF.Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.A massive potential marketIn the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.Better than Tesla?To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":851090164,"gmtCreate":1634857328674,"gmtModify":1634857328782,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"What a drastic droo","listText":"What a drastic droo","text":"What a drastic droo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851090164","repostId":"2177640184","repostType":4,"isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858088875,"gmtCreate":1634953290793,"gmtModify":1634954241447,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858088875","repostId":"1166213725","repostType":4,"repost":{"id":"1166213725","kind":"news","pubTimestamp":1634948473,"share":"https://www.laohu8.com/m/news/1166213725?lang=zh_CN&edition=full","pubTime":"2021-10-23 08:21","market":"us","language":"en","title":"Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166213725","media":"Barrons","summary":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?Tesla  stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.Tesla stoc","content":"<p>Tesla&nbsp;stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高，收盘价创历史新高。该股最近的走势令人难以置信。能涨到多高？</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The&nbsp;S&amp;P 500&nbsp;dropped about 0.1%, while the&nbsp;Dow Jones Industrial Average&nbsp;added about 0.2%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收于909.68美元，上涨约1.8%。标准普尔500指数下跌约0.1%，道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&amp;P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五，标准普尔的信用升级也提振了股价。特斯拉债务目前评级为BB+，比投资级低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股价创52周盘中新高910美元。根据道琼斯市场数据，900.40美元的旧高水位是在1月25日创下的。周四，特斯拉自1月26日以来首次收于创纪录水平。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月，股价上涨了约40%，市值达到约9100亿美元。（特斯拉拥有约10亿股已发行股票，这使得计算变得很容易。）</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到未来会有更多收益。Wedbush分析师Dan Ives将牛市特斯拉股价目标从1300美元上调至1500美元，此前该公司周三公布了好于预期的财报。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“特斯拉正在上涨，因为盈利修正正在飙升，”未来基金主动交易所交易基金管理合伙人Gary Black指出。过去几周，分析师对特斯拉2022年每股收益的预期已从每股6美元升至约8美元。“不断上涨的估值推动特斯拉在2020年登上了月球。它们将推动特斯拉在2022年达到1,000美元以上，”Black说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>Ives将特斯拉股票评级为买入，特斯拉是Black基金的最大持仓。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的，仍然有看空特斯拉的人认为该股被高估了。分析师目标价的底部三分之一平均约为425美元，不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票通常不会因为投资者集体某天早上醒来对估值有不同的感觉而下跌。总得有事发生。整体市场可能会暴跌，或者企业可能会陷入困境。分析师预计，特斯拉的交付量将从2021年的约89万辆增长到2022年的130万辆。增长的任何问题都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌，谁也说不准。不过，就目前而言，势头属于特斯拉多头。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于900美元以上。接下来会发生什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-23 08:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla&nbsp;stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高，收盘价创历史新高。该股最近的走势令人难以置信。能涨到多高？</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The&nbsp;S&amp;P 500&nbsp;dropped about 0.1%, while the&nbsp;Dow Jones Industrial Average&nbsp;added about 0.2%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收于909.68美元，上涨约1.8%。标准普尔500指数下跌约0.1%，道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&amp;P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五，标准普尔的信用升级也提振了股价。特斯拉债务目前评级为BB+，比投资级低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股价创52周盘中新高910美元。根据道琼斯市场数据，900.40美元的旧高水位是在1月25日创下的。周四，特斯拉自1月26日以来首次收于创纪录水平。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月，股价上涨了约40%，市值达到约9100亿美元。（特斯拉拥有约10亿股已发行股票，这使得计算变得很容易。）</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到未来会有更多收益。Wedbush分析师Dan Ives将牛市特斯拉股价目标从1300美元上调至1500美元，此前该公司周三公布了好于预期的财报。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“特斯拉正在上涨，因为盈利修正正在飙升，”未来基金主动交易所交易基金管理合伙人Gary Black指出。过去几周，分析师对特斯拉2022年每股收益的预期已从每股6美元升至约8美元。“不断上涨的估值推动特斯拉在2020年登上了月球。它们将推动特斯拉在2022年达到1,000美元以上，”Black说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>Ives将特斯拉股票评级为买入，特斯拉是Black基金的最大持仓。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的，仍然有看空特斯拉的人认为该股被高估了。分析师目标价的底部三分之一平均约为425美元，不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票通常不会因为投资者集体某天早上醒来对估值有不同的感觉而下跌。总得有事发生。整体市场可能会暴跌，或者企业可能会陷入困境。分析师预计，特斯拉的交付量将从2021年的约89万辆增长到2022年的130万辆。增长的任何问题都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌，谁也说不准。不过，就目前而言，势头属于特斯拉多头。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166213725","content_text":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?\nTesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.\nShares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.\nTesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.\nShares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)\nBulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.\n“Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.\nIves rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.\nYes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.\nBears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.\nWhether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":350945833,"gmtCreate":1616155073822,"gmtModify":1634526972633,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/350945833","repostId":"1197074607","repostType":4,"repost":{"id":"1197074607","kind":"news","pubTimestamp":1616152229,"share":"https://www.laohu8.com/m/news/1197074607?lang=zh_CN&edition=full","pubTime":"2021-03-19 19:10","market":"us","language":"en","title":"Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197074607","media":"Motley Fool","summary":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesT","content":"<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上升潜力。几乎每个人都知道凯西·伍德真的很喜欢<b>特斯拉</b>（纳斯达克：TSLA）。方舟投资管理公司创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时，伍德通常会为她雄心勃勃的交易所交易基金购买更多股票。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的ETF中的许多其他持股并没有受到那么多关注。然而，她本月早些时候在接受CNBC采访时指出了其中一只股票，称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它是否比特斯拉更值得买入？</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德特别提到了医学遗传学领导者<b>邀请</b>（纽约证券交易所股票代码：NVTA）是一只特别被低估的股票。该公司表示，其使命“是将全面的遗传信息带入主流医学，以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此，她管理的两只ETF持有Invitae的头寸也就不足为奇了。该股是该公司第11大持股<b>方舟创新ETF</b>和第17大持股<b>方舟基因组革命ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病遗传给孩子的风险，以及最合适的胚胎，以帮助确保在体外受精过程中确定健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中，Invitae过去12个月的收入猛增了2,400%以上。这一业绩超过了特斯拉同期约640%的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而，与特斯拉不同的是，Invitae尚未盈利。但这家基因检测公司在未来几年内有一条盈利之路，特别是随着最近收购ArcherDX和One Codex扩大Invitae的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去，基因检测的高成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本，打开了巨大潜在市场的大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae首席执行官肖恩·乔治(Sean George)上周告诉CNBC，基因检测的情况与大约四十年前计算和网络行业发生的情况类似。当时较低的半导体成本为市场爆炸奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大？Invitae认为其潜在市场总额每年超过1500亿美元。它预计，仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计，41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为，它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单，预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好？</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是，到目前为止，Invitae还没有像特斯拉那样成为大赢家。在过去五年中，医疗保健股的价值增长了五倍。然而，在同一时期，特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看，Invitae会比特斯拉更好吗？当在去年12月接受彭博社采访时被问及哪只股票可能在未来五年内推动ARK ETF的最大涨幅时，伍德承认特斯拉是其中之一。然而，她也表示，“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着Invitae一定是将成为未来主要意外赢家的基因组学股票。不过，也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司的市值目前仅为85亿美元左右。如果Invitae在其目标市场中占据两位数的份额，它可能会成为10家企业。尽管特斯拉取得了巨大的成功，但想象该股再次成为10袋股还有些牵强。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>现在Invitae可能比特斯拉更划算。不过，即使事实并非如此，该股也很有可能不会在太长时间内保持低估状态。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的Cathie Wood股票现在比特斯拉更值得买入吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-19 19:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上升潜力。几乎每个人都知道凯西·伍德真的很喜欢<b>特斯拉</b>（纳斯达克：TSLA）。方舟投资管理公司创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时，伍德通常会为她雄心勃勃的交易所交易基金购买更多股票。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的ETF中的许多其他持股并没有受到那么多关注。然而，她本月早些时候在接受CNBC采访时指出了其中一只股票，称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它是否比特斯拉更值得买入？</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德特别提到了医学遗传学领导者<b>邀请</b>（纽约证券交易所股票代码：NVTA）是一只特别被低估的股票。该公司表示，其使命“是将全面的遗传信息带入主流医学，以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此，她管理的两只ETF持有Invitae的头寸也就不足为奇了。该股是该公司第11大持股<b>方舟创新ETF</b>和第17大持股<b>方舟基因组革命ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病遗传给孩子的风险，以及最合适的胚胎，以帮助确保在体外受精过程中确定健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中，Invitae过去12个月的收入猛增了2,400%以上。这一业绩超过了特斯拉同期约640%的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而，与特斯拉不同的是，Invitae尚未盈利。但这家基因检测公司在未来几年内有一条盈利之路，特别是随着最近收购ArcherDX和One Codex扩大Invitae的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去，基因检测的高成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本，打开了巨大潜在市场的大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae首席执行官肖恩·乔治(Sean George)上周告诉CNBC，基因检测的情况与大约四十年前计算和网络行业发生的情况类似。当时较低的半导体成本为市场爆炸奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大？Invitae认为其潜在市场总额每年超过1500亿美元。它预计，仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计，41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为，它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单，预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好？</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是，到目前为止，Invitae还没有像特斯拉那样成为大赢家。在过去五年中，医疗保健股的价值增长了五倍。然而，在同一时期，特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看，Invitae会比特斯拉更好吗？当在去年12月接受彭博社采访时被问及哪只股票可能在未来五年内推动ARK ETF的最大涨幅时，伍德承认特斯拉是其中之一。然而，她也表示，“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着Invitae一定是将成为未来主要意外赢家的基因组学股票。不过，也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司的市值目前仅为85亿美元左右。如果Invitae在其目标市场中占据两位数的份额，它可能会成为10家企业。尽管特斯拉取得了巨大的成功，但想象该股再次成为10袋股还有些牵强。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>现在Invitae可能比特斯拉更划算。不过，即使事实并非如此，该股也很有可能不会在太长时间内保持低估状态。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197074607","content_text":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesTesla(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.What is this underappreciated stock -- and could it be an even better buy than Tesla?It's in the genesWood singled out medical genetics leaderInvitae(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in theARK Innovation ETFand the 17th-largest holding in theARK Genomic Revolution ETF.Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.A massive potential marketIn the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.Better than Tesla?To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}